// App-Quantinova.ai

P3-07-05 : Correlation between and molecular drivers of oncotype DX, prosigna, EndoPredict and breast cancer index: A TransATAC study

Researchers

Presenter

  • Richard Buus

Principal Investigators

  • Ivana Sestak

  • Mitch Dowsett

  • Ralf Kronenwett

  • Sean Ferree

  • Catherine Schnabel

  • Frederick L Baehner

  • Jack Cuzick

Medical Centers

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • Queen Mary University of London, London, United Kingdom

  • Myriad International GmBH, Köln, Germany

  • NanoString Technologies, Inc., Seattle, WA

  • bioTheranostics, San Diego, CA

  • Genomic Health, Inc., Redwood City, CA

Locations

  • United Kingdom

  • Germany

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Myb-related protein B

  • Aurora kinase A

  • B-cell lymphoma 2

  • Progesterone receptor

  • Proliferation marker protein Ki-67

  • Cyclin B1

  • erb-b2 receptor tyrosine kinase 2

  • Growth factor receptor bound protein 7

  • Matrix Metallopeptidase 11

  • Signal Peptide, CUB Domain And EGF Like Domain Containing 2

Drug/Treatment

  • Anastrozole

  • Tamoxifen

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved